Skip to content
10-Q

Quarterly Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-23-000146

← back to feed
Filed
Aug 1, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q2 2023 · Jun 30, 2023 $654
Cash And Equivalents Q2 2023 · Dec 31, 2022 $734
Current Liabilities Q2 2023 · Jun 30, 2023 $1.59M
Current Liabilities Q2 2023 · Dec 31, 2022 $1.35M
Total Liabilities Q2 2023 · Jun 30, 2023 $1.59M
Total Liabilities Q2 2023 · Dec 31, 2022 $1.35M
Current Assets Q2 2023 · Jun 30, 2023 $654
Current Assets Q2 2023 · Dec 31, 2022 $734
Total Assets Q2 2023 · Jun 30, 2023 $654
Total Assets Q2 2023 · Dec 31, 2022 $734
Shares Outstanding Q2 2023 · Jul 26, 2022 29.27M sh
Shares Diluted Q2 2023 · Jun 30, 2022 29.27M sh
Shares Diluted Q2 2023 · Jun 30, 2022 29.27M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$42.57K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$1.11M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$994.27K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$861.86K
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.01
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 −$0.01
Sga Expense Q2 2023 · Jun 30, 2022 $10.03K
Sga Expense Q2 2023 · Jun 30, 2022 $36.69K
Net Income Q2 2023 · Jun 30, 2022 −$115.78K
Net Income Q2 2023 · Jun 30, 2022 −$248.19K